Clinical Trials
3 trialsNCT05784415 2026-02-02
CS22-03
AIDS Malignancy Consortium
Completed
NCT02924402 2024-11-13
Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies
Xencor, Inc.
Phase 1 Completed
NCT02652715 2019-11-15
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
Mayo Clinic
Phase NA Completed